TriLytewith Flavor Packs (Wallace Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the TriLyte drug offered from Wallace Pharmaceuticals Inc.. This Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Wallace Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Polyethylene glyocol 3350, sodium chloride, sodium bicarbonate and potassium chloride |
SUBSTANCE NAME: | POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
ROUTE: | NASOGASTRIC; ORAL |
DOSAGE FORM: | POWDER, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-09-23 |
END MARKETING DATE: | 0000-00-00 |
TriLyte with Flavor Packs HUMAN PRESCRIPTION DRUG Details:
Item Description | TriLyte with Flavor Packs from Wallace Pharmaceuticals Inc. |
LABELER NAME: | Wallace Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 420; 11.2; 5.72; 1.48(g/4L; g/4L; g/4L; g/4L) |
START MARKETING DATE: | 2013-09-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51525-6831_486598b0-0358-11e3-8ffd-0800200c9a66 |
PRODUCT NDC: | 51525-6831 |
APPLICATION NUMBER: | ANDA076491 |
Other POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE Pharmaceutical Manufacturers / Labelers: